The mission of the Cancer Genomics Shared Resource (CGSR) is to provide Masonic Cancer Center (MCC) investigators with broad, deep, and affordable access to state-of-the-art genomic services. In addition to maintaining a world-class suite of genomic instrumentation, the Directors and staff of the CGSR help advance investigators' science through consultation about technology choices and workflows, including upstream preparative and downstream bioinformatics and data interpretation steps. The skilled staff can perform all of the technical components of the work or can collaborate with the investigator's own laboratory staff, providing training and access to equipment they would otherwise not be able to utilize. CGSR assays range from conventional cytogenetics to the most current single-cell and next-generation sequencing technologies. These enable MCC researchers to address critical questions relevant to the etiology, behavior, and treatment of hematologic and solid tumors. There is no other resource at the University of Minnesota that provides these services to researchers. The structure and name of this Shared Resource was changed during the last funding cycle. Specifically, the Cytogenomics Shared Resource merged with the services of the University of Minnesota Genomics Center (UMGC) to become the CGSR. The CGSR, co-directed by Drs. Betsy Hirsch and Kenneth Beckman, with expertise in cytogenomics and molecular genomic technologies, respectively, will simplify navigation by MCC members through the complex spectrum of genomic assays offered at the UMN. The CGSR will ensure focused attention on the specific scientific needs of MCC investigators while benefitting from the synergies resulting from integration with the UMGC which serves the entire University community. In the new CGSR, there will be an additional PhD-level full-time equivalent (FTE) Research Scientist devoted specifically to customized work for MCC members, facilitating the development of novel assays, generation of pilot data, and the advancement of cancer research projects.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Mondragon-Gonzalez, Ricardo; Perlingeiro, Rita C R (2018) Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech 11:
Kim, J-H; Frantz, A M; Sarver, A L et al. (2018) Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 16:E176-E184
Jin, Jin; Zhang, Lin; Leng, Ethan et al. (2018) Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Stat Med 37:3214-3229
Pierpont, Elizabeth I; Hudock, Rebekah L; Foy, Allison M et al. (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21
Carlson, Erik S; Upadhyaya, Pramod; Villalta, Peter W et al. (2018) Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-p Chem Res Toxicol 31:358-370
Lin, Lifeng; Chu, Haitao; Murad, Mohammad Hassan et al. (2018) Empirical Comparison of Publication Bias Tests in Meta-Analysis. J Gen Intern Med 33:1260-1267
Rashidi, Armin; Ebadi, Maryam; Said, Bassil et al. (2018) Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect. Am J Hematol :
Bejanyan, Nelli; Brunstein, Claudio G; Cao, Qing et al. (2018) Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv 2:909-922
Bachanova, Veronika; Sarhan, Dhifaf; DeFor, Todd E et al. (2018) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunol Immunother 67:483-494
Hupp, Meghan; Williams, Sarah; Dunnette, Brian et al. (2018) Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas. Hum Pathol :

Showing the most recent 10 out of 1013 publications